| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2972936 | The Journal of Heart and Lung Transplantation | 2006 | 7 Pages |
Abstract
Monitoring of the C2 rather than the C0 level better reflects immunosuppressive efficiency and identifies patients at increased risk of acute rejection. A C2 level of >600 ng/ml should be the target to prevent acute rejection.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
S. MD, H. MD, PhD, H.B. MD, M. MD, M.Y. MD, O. MD, P. MD, PhD, Y. MD, H. MD, B. MD, R. MD, PhD, F. MD, PhD,